Antimicrobial symposium. Part IV. Cephalosporins.
Cooper
Travis W
TW
Department of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, USA.
Gibbs
Winter J
WJ
Bronze
Michael S
MS
Greenfield
Ronald A
RA
D000890:Anti-Infective Agents / Q000145:classification / Q000494:pharmacology*; D002511:Cephalosporins / Q000145:classification / Q000494:pharmacology*; D016993:Chlamydophila pneumoniae / Q000187:drug effects; D017714:Community-Acquired Infections / Q000188:drug therapy; D003428:Cross Infection / Q000188:drug therapy; D024901:Drug Resistance, Multiple, Bacterial; D016983:Enterococcus / Q000187:drug effects; D006801:Humans; D016952:Legionella pneumophila / Q000187:drug effects; D009177:Mycoplasma pneumoniae / Q000187:drug effects; D013211:Staphylococcus aureus / Q000187:drug effects; D013212:Staphylococcus epidermidis / Q000187:drug effects
D000890:Anti-Infective Agents; D002511:Cephalosporins